Eric Matthew Button Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4300 Maple Ave, Halethorpe, MD 21227 Phone: 443-809-1406 |
Gabrielle M Edwards Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4300 Maple Ave, Halethorpe, MD 21227 Phone: 410-887-1406 |
Taniya Jiwani Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2011 Hammonds Ferry Rd, Halethorpe, MD 21227 Phone: 678-314-1745 |
News Archive
A recent study by Canadian and US researchers demonstrates how frameshift signals of coronaviruses represent a viable target for developing novel therapeutics with broad-spectrum activity – not only against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but also other constituents of the coronavirus family. The study is currently available on the bioRxiv* preprint server while it undergoes peer review.
AstraZeneca has announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for once- daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of major depressive disorder (MDD) as monotherapy, adjunct therapy, and maintenance therapy in adult patients.
There may soon be a better way to fight unsightly wrinkles. Researchers have discovered a novel way to increase the potency of botulinum neurotoxin treatments - commonly known as Botox - that they say could one day allow patients to receive the injections less frequently while maintaining or even enhancing its cosmetic benefits.
Parker Hannifin Corporation, the global leader in motion and control technologies, today announced the establishment of the Instrumentation Group's Instrumentation Solution Centers, a special distinction given to its top-performing North American distributors.
› Verified 7 days ago